Survey suggests Britons with a disability are concerned over AI-integrated healthcare
Ella Day | April 14, 2025 | News story | Business Services, Consultancy, Medical Communications | AI, Consultancy, Corporate, Pharmacy, nuom, survey
A survey conducted by nuom, a British healthcare consultancy, found a majority of UK adults with a disability are concerned that artificial intelligence (AI)-integrated healthcare could prioritise efficiency over inclusivity. Nuom emphasises the need for inclusive technologies that are developed with those with disabilities as AI in healthcare continues to develop.
In collaboration with independent market research agency, Opinium, the survey explored attitudes and perspectives of Britons with disabilities on the recently developed AI-assisted healthcare technology. It was carried out between 31 January and 4 February 2025 among 2,000 Britons with disabilities with the sample deemed nationally representative.
The research found that nearly two-thirds (65%) of respondents believed that AI-integrated healthcare could prioritise speed and efficiency over personal human support, of which many patients rely on. Most feel like many Britons with disabilities will be left behind as (73%) agreed that individuals who lack confidence in using technology will be excluded. Moreover, 74% thought that companies that design such technology must develop models with input from people with disabilities to ensure accessibility.
Managing partner at nuom, Martin Sandhu, commented: “Our research shows that many people with disabilities fear being left behind by rapid developments in healthcare technologies. That’s why it’s essential they’re involved in the design and development process from the start.”
The survey also found that AI-assisted tools can provide valuable support; almost half of respondents (48%) expressed that they find such tools helpful and trustworthy. Sandhu added: “AI has the potential to improve accessibility, offer more personalised care, and support greater independence. But to get there, we need to build systems that work for everyone.”
Ella Day
14/4/25
Related Content
Cellbyte raises $2.75m to fund pharma drug launch platform
Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of …
MultiOmic Health and BIO4 Campus sign collaborative Memorandum of Understanding
MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company and BIO4 Campus (BIO4), …
Sanome’s AI tool gains certification for early detection of hospital infections
Sanome’s MEMORI, an artificial intelligence (AI) medical device that can predict hospital-acquired infections up to …
